Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Qiagen N.V.
  6. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/18/2022 01/19/2022 01/20/2022 01/21/2022 01/24/2022 Date
48.44(c) 49.79(c) 49.57(c) 48.69(c) 48.81 Last
1 241 314 2 082 800 1 136 314 863 709 716 588 Volume
-0.08% +2.79% -0.44% -1.78% +0.25% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 2 198 M - -
Net income 2021 473 M - -
Net Debt 2021 941 M - -
P/E ratio 2021 23,3x
Yield 2021 -
Sales 2022 2 064 M - -
Net income 2022 396 M - -
Net Debt 2022 537 M - -
P/E ratio 2022 29,2x
Yield 2022 -
Capitalization 11 081 M 11 081 M -
EV / Sales 2021 5,47x
EV / Sales 2022 5,63x
Nbr of Employees 6 000
Free-Float 97,8%
More Financials
Company
Qiagen N.V. is one of the world's leaders in designing, manufacturing, and marketing chemical products for the isolation, purification, and manipulation of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid). In 2019, the group developed more than 500 consumable products and automated solutions through its 35 production sites worldwide. Net sales break down geographically as follows: the United States (43.5%),... 
Sector
Biotechnology & Medical Research
Calendar
02/08 | 04:05pmEarnings Release
More about the company
Ratings of Qiagen N.V.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about QIAGEN N.V.
01/21QIAGEN N : Earnings Document
PU
01/19Qiagen N.V Launched Higher on M&A Chatter
MT
01/19QIAGEN N : supports young biotechnology and pharma companies by announcing winners of firs..
PU
01/19QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021
BU
01/18QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products
BU
01/18QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products
CI
01/18DZ Bank Upgrades Qiagen to Buy from Hold, Raises Price Target to $59.34 From $55.79
MT
01/17ANALYST RECOMMENDATIONS : Admiral, Hiscox, National Grid, Qiagen, Unilever...
01/17QIAGEN NV : DZ Bank takes a positive view
MD
01/13QIAGEN N : liquid-based sample-prep-and-detection kit helps labs ramp up COVID testing cap..
PU
01/10QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIA..
BU
01/10QIAGEN Expands QIAstat-Dx Syndromic Testing Menu and Announces Launch Plans for New QIA..
CI
01/07QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcu..
BU
01/07QIAGEN N.V. Enters New Collaborations
CI
01/06QIAGEN Expands QuantiFERON Portfolio in the Fight Against TB
BU
More news
News in other languages on QIAGEN N.V.
01/19AKTIEN FRANKFURT SCHLUSS : Nicht wirklich erholt
01/19MÄRKTE EUROPA/Sehr volatil - Richemont und Burberry überzeugen
01/19XETRA-SCHLUSS/DAX schließt nach Berg- und Talfahrt etwas fester
01/18QIAGEN führt mit QIAwave umweltfreundliche Produktlinie ein
01/18QIAGEN lance le portefeuille QIAwave de produits respectueux de l'environnement
More news
Analyst Recommendations on QIAGEN N.V.
More recommendations
Chart QIAGEN N.V.
Duration : Period :
Qiagen N.V. Technical Analysis Chart | QGEN | NL0012169213 | MarketScreener
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 48,69 $
Average target price 57,79 $
Spread / Average Target 18,7%
EPS Revisions
Managers and Directors
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Vice President-Finance
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
QIAGEN N.V.-12.40%11 054
MODERNA, INC.-36.98%64 900
LONZA GROUP AG-15.65%52 307
IQVIA HOLDINGS INC.-14.60%46 031
SEAGEN INC.-17.50%23 323
ICON PUBLIC LIMITED COMPANY-18.65%20 508